An Open-label, Flexibly-dosed, 26-Week Extension Safety Study of Dasotraline in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD)
Clinical Trial Grant
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Sunovion Pharmaceuticals, Inc
Start Date
September 15, 2015
End Date
September 14, 2016
Administered By
Psychiatry & Behavioral Sciences
Awarded By
Sunovion Pharmaceuticals, Inc
Start Date
September 15, 2015
End Date
September 14, 2016